FDA Inspection 1242874 — Brigiette Kalsch, M.D.
The FDA completed an inspection of Brigiette Kalsch, M.D. on Jun 14, 2024 in Mannheim. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 14, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mannheim (Germany)
Additional Details
Clinical BA/BE